tiprankstipranks
Medicure Announces Q1 Revenue Growth and Board Election
Company Announcements

Medicure Announces Q1 Revenue Growth and Board Election

Medicure (TSE:MPH) has released an update.

Don't Miss Our Christmas Offers:

Medicure Inc., specializing in pharmaceuticals for the U.S. market, has reported a slight increase in total net revenue, reaching $5.7 million for the first quarter of 2024, with Marley Drug business showing significant growth. The company also announced a successful election of its Board of Directors, with over 99% votes in favor of the listed nominees, including the addition of Kim Kline, a seasoned bioscience industry leader.

For further insights into TSE:MPH stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskMedicure Sees Revenue Growth in Q3 2024
TipRanks Canadian Auto-Generated NewsdeskMedicure Acquires Promising New Chemical Entities
TipRanks Canadian Auto-Generated NewsdeskMedicure Reveals Downturn in Q2 2024 Financials
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App